Karl Ho graduated from The University of Toronto. He started off his career at various bulge bracket investment banks including HSBC,  Goldman Sachs and Credit Suisse where he was responsible for the origination and execution of IPOs and M&As for companies in various industries and geographies including real estate, financial institutions, retail and energy in regions such as Hong Kong, China and parts of Southeast Asia. Subsequently, he took on the role as Head of Investor Relations and Corporate Finance at China Resources Power (836.HK) and more recently Novotech Health Holdings where he played a critical role in strategies and value creation planning, capital raising, formulating the investment story, managing the expectations of the investment community such as institutional investors and sell-side equity research analysts, as well as identification, screening, and execution of acquisition projects.